Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_assertion type Assertion NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_head.
- NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_assertion wasGeneratedBy ECO_0000203 NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_provenance.
- NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_assertion wasDerivedFrom befree-20150227 NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_provenance.
- NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_assertion SIO_000772 21389325 NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_provenance.
- NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_assertion evidence source_evidence_literature NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_provenance.
- NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_assertion description "[These observations have resulted in a number of recent clinical trials utilizing IFNα in patients with chronic myeloid leukemia (CML), systemic mast cell disease, hypereosinophilic syndrome and the Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) with promising outcomes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477708.RApWyERFUdJ49jQLKesYbVOwSzGCMYX6fOQ7RzcYBcucQ130_provenance.